Sanofi Genzyme National severe Atopic Dermatitis (AD) Advisory Board “AD clinical practice in Latvia. Dupilumab place in managing patients with severe AD”

Activity: Consultancy types › Consultancy

Period19 Nov 2020
Event titleSanofi Genzyme National severe Atopic Dermatitis (AD) Advisory Board “AD clinical practice in Latvia. Dupilumab place in managing patients with severe AD”
Event typeMeeting
LocationRiga, LatviaShow on map
Degree of RecognitionNational

Keywords

  • Atopic dermatitis
  • Biotherapy

Field of Science

  • 3.2 Clinical medicine